CrossrefInfokarte
Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma
Journal of Clinical Pharmacy and Therapeutics · 2022-12 · 47 (12) · 2196-2204
DOI: 10.1111/jcpt.13791 ↗Abstract
Kein Abstract verfügbar.
EUVIMED